Acquisition of Viridian Pharma Ltd

Acquisition of Viridian Pharma Ltd by Martindale Pharma

As of 1 July 2016 Martindale Pharma completed the acquisition of Viridian Pharma and has assumed responsibility for all on-going operations of the business. A copy of the press release announcing this deal can be found here.

The Viridian Pharma portfolio complements Martindale Pharma’s range of hospital-initiated and emergency care medicines and fits our strategy to grow our product range.

There will be no immediate change to the way Viridian Pharma’s sodium citrate oral solution, peppermint water and sodium chloride oral solution products are supplied to pharmacies in the community and hospitals and there is no need for Viridian Pharma customers to change the way they order products.

Martindale Pharma already markets the caffeine citrate injection and caffeine citrate oral solution products owned by Viridian Pharma and those arrangements also remain unchanged.

There are new contact details for any enquiries related to the Viridian Pharma portfolio and these are detailed below:-

For UK enquiries on purchasing or ordering Viridian Pharma products contact customer services on:

Telephone: 0800 0287933

For medical information or drug safety enquiries on Viridian Pharma products:

Telephone: 01628 551900
Email:  or

For International i.e. ex-UK enquiries on purchasing or ordering Viridian Pharma products:

Telephone: +44 (0)1277 235331

For enquiries in relation to manufacturing or product quality (complaints) for Viridian Pharma products please contact:

Telephone: 01628-551900

For enquiries in relation to payments or other financial matters to or from Viridian Pharma please contact:

Telephone: 01628 551916

For any other enquiry around Viridian Pharma including business development, marketing, licensing, please contact:

Telephone: 01628 551934